Co-Diagnostics, Inc. says its ground-breaking CoPrimer technology will be featured at the International Plant & Animal Genome XXVIII conference


Co-Diagnostics, Inc. says its ground-breaking CoPrimer technology will be featured at the International Plant & Animal Genome XXVIII conference

The group said the evaluation of BHQplex CoPrimers in flexible PCR-based genotyping will be presented by a representative of Bayer-Crop Science

, Inc. (), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, said Tuesday that its ground-breaking CoPrimer technology will be featured at the International Plant & Animal Genome XXVIII conference, held on January 11-15 in San Diego, California.

The group said the evaluation of BHQplex CoPrimers in flexible PCR-based genotyping will be presented by a representative of Bayer-Crop Science on Monday, January 13, in a presentation titled ‘CoPrimer Assays for Multiplex PCR.’

According to the presentation abstract, Bayer evaluated the patented technology’s ability to enable robust and flexible multiplexing for PCR-based genotyping in several assays.

This included successfully testing their performance in many different combinations and plex-levels using qPCR, end-point and digital PCR. BHQplex CoPrimers utilize the Company’s patented CoPrimer technology as branded by LGC Biosearch, whose footprint covers over 200 countries.

The company said it intends to provide additional information concerning the importance of these findings following the presentation.


Source link